NImmune Biopharma, a late-clinical-stage biopharmaceutical company specializing in precision inflammation and immunology (I&I) therapeutics, has announced the acquisition of development and commercialization rights to omilancor across several Asian markets, including…
Opioid use in California’s workers’ compensation system has decreased more rapidly than in the state’s general population, according to a new analysis by the California Workers’ Compensation Institute (CWCI) based…
Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the emerging space economy, has announced an exciting new mission to the International Space Station (ISS) in collaboration with global…
Bioptimus’ H-optimus-0 Model Now Integrated with Proscia’s Concentriq® for Fast AI Development Bioptimus, a leading French AI startup, has announced the integration of its H-optimus-0 foundation model into Proscia’s Concentriq®…
Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, has announced expanded capabilities for its lung disease software. The new features incorporate natural language processing (NLP) alongside imaging…
Nucleus RadioPharma announced the development of two new facilities, totaling over 100,000 square feet, in Mesa, Arizona, and Spring House, Pennsylvania. These state-of-the-art sites will integrate research, development, and commercial…
Kolmar BNH (KRX: 200130), the manufacturer of the immune-boosting health supplement HemoHim, has gained international recognition for its product quality from both the U.S. Food and Drug Administration (FDA) and…
Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic…
Waltz Health, a digital health company developing smarter, technology-enabled ways to price, distribute and prescribe medications and Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people…
VSee Health, Inc. (Nasdaq: VSEE), a leading provider of telehealth services that optimize workflow and enhance patient care, has launched a new program to address obesity and related health risks…
NUCLIDIUM today announced the successful imaging of the first patient in a Phase 1 clinical trial evaluating its radiotracer candidate as a safe and effective diagnostic and disease-staging tool in…
Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the closing of an oversubscribed $225…